• Profile
Close

Randomised assessor-masked trial evaluating topical manuka honey (Optimel) in treatment of meibomian gland dysfunction

British Journal of Ophthalmology Jan 13, 2021

Li ALW, Li SL, Kam KW, et al. - Researchers conducted the study for assessing the impacts of manuka honey eye-drops in the treatment of meibomian gland dysfunction. This was an assessor-masked (single-blind), randomised controlled trial contrasting conventional treatment group with interventional group utilizing Optimel 16% manuka honey topical eye-drops. Fifty-nine patients were selected to the study and randomised into two groups: one given regular lubricants and the other given Optimel 16% manuka honey eye-drops. Optimel 16% manuka honey eye-drops have demonstrated substantial improvement in meibomian gland dysfunction symptoms and objective signs and are an efficient alternative treatment for meibomian gland dysfunction.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay